Global, regional and national burden of Glaucoma: an update analysis from the Global Burden of Disease Study 2019.
Disability-adjusted life years
Glaucoma
Global Burden of Disease
Prevalence
Journal
International ophthalmology
ISSN: 1573-2630
Titre abrégé: Int Ophthalmol
Pays: Netherlands
ID NLM: 7904294
Informations de publication
Date de publication:
19 Jun 2024
19 Jun 2024
Historique:
received:
21
01
2023
accepted:
16
06
2024
medline:
19
6
2024
pubmed:
19
6
2024
entrez:
19
6
2024
Statut:
epublish
Résumé
As the epidemiological and burden trends of glaucoma are changing, it is extremely necessary to re-investigate geographical differences and trends. Here we use data from the 2019 Global burden of Disease, which aims to report the prevalence and disability-adjusted life years of glaucoma injury to assess the latest epidemiological models and trends from 1990 to 2019. Annual case numbers, age-standardized rates of prevalence, DALYs, and their estimated annual percentage changes (EAPCs) for glaucoma between 1990 and 2019 were derived from the GBD 2019 study. The relationship between glaucoma disease burden and social demographic index (SDI) was also investigated in this study. In 2019, there were 7.47 million prevalent cases and 0.75 million DALYs cases, which increased by 92.53% and 69.23% compared with 1990 respectively. The global age-standardized rate of prevalence (ASPR) and age-standardized rate of DALYs (ASDR) decreased during 1990-2019 (EAPC = - 0.55 and - 1, respectively). In 2019, the highest ASPR and ASDR of Glaucoma were all observed in Mali, whereas the lowest occurred in Taiwan (Province of China). In terms of gender, males were more likely to suffer from glaucoma than females, especially the elderly. The global prevalence and DALYs of glaucoma had an absolute increase during the past 30 years. The disease burden caused by glaucoma is closely related to socioeconomic level, age, gender, and other factors, and these findings provide a basis for policymakers from the perspective of social management.
Identifiants
pubmed: 38896279
doi: 10.1007/s10792-024-03222-6
pii: 10.1007/s10792-024-03222-6
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
234Subventions
Organisme : the Traditional Chinese Medicine Science and Technology Plan Project of Zhejiang Province
ID : 2024ZR029
Organisme : the Basic Public Welfare Research Projects of Wenzhou Science and Technology Bureau
ID : Y2023210
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
Références
Jayaram H, Kolko M, Friedman DS et al (2023) Glaucoma: now and beyond. Lancet 402:1788–1801
doi: 10.1016/S0140-6736(23)01289-8
Razeghinejad R, Lin MM, Lee D et al (2020) Pathophysiology and management of glaucoma and ocular hypertension related to trauma. Surv Ophthalmol 65:530–547
doi: 10.1016/j.survophthal.2020.02.003
Stein JD, Khawaja AP, Weizer JS (2021) Glaucoma in adults-screening, diagnosis, and management: a review. JAMA 325:164–174
doi: 10.1001/jama.2020.21899
Kaplan RI, De Moraes CG, Cioffi GA et al (2015) Comparative cost-effectiveness of the baerveldt implant, trabeculectomy with mitomycin, and medical treatment. JAMA Ophthalmol 133:560–567
doi: 10.1001/jamaophthalmol.2015.44
GBD 2019 Viewpoint Collaborators (2020) Five insights from the Global Burden of Disease Study 2019. Lancet 396:1135–1159
doi: 10.1016/S0140-6736(20)31404-5
Zou M, Zhang Y, Chen A et al (2021) Variations and trends in global disease burden of age-related macular degeneration: 1990–2017. Acta Ophthalmol 99:e330–e335
doi: 10.1111/aos.14589
GBD 2016 DALYs and HALE Collaborators (2017) Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390:1260–1344
doi: 10.1016/S0140-6736(17)32130-X
Lin Y, Jiang B, Cai Y et al (2023) The global burden of Glaucoma: findings from the Global Burden of Disease 2019 study and predictions by Bayesian age-period-cohort analysis. J Clin Med 12:1828
doi: 10.3390/jcm12051828
Sun H, Wang G, Feng Q et al (2023) Polymer-based self-assembled drug delivery systems for glaucoma treatment: design strategies and recent advances. Polymers (Basel) 15:4466
doi: 10.3390/polym15224466
Mensah GA, Roth GA, Fuster V (2019) The global burden of cardiovascular diseases and risk factors: 2020 and beyond. J Am Coll Cardiol 74:2529–2532
doi: 10.1016/j.jacc.2019.10.009
Jin LJ, Lamster IB, Greenspan JS et al (2016) Global burden of oral diseases: emerging concepts, management and interplay with systemic health. Oral Dis 22:609–619
doi: 10.1111/odi.12428
Yang X, Zhang T, Zhang Y et al (2021) Global burden of COPD attributable to ambient PM2.5 in 204 countries and territories, 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Sci Total Environ 796:148819
doi: 10.1016/j.scitotenv.2021.148819
Cohen SS, Bylsma LC, Movva N et al (2022) Theoretical attributable risk analysis and disability adjusted life years (DALYs) based on increased dairy consumption. BMC Public Health 22:1625
doi: 10.1186/s12889-022-14042-7
GBD 2019 Healthcare Access and Quality Collaborators (2022) Assessing performance of the healthcare access and quality index, overall and by select age groups, for 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet Glob Health 10:e1715–e1743
doi: 10.1016/S2214-109X(22)00429-6
Karamitanha F, Ahmadi F, Fallahabadi H (2023) Difference between various countries in mortality and incidence rate of the atrial fibrillation based on human development index in worldwide: data from global burden of disease 2010–2019. Curr Probl Cardiol 48:101438
doi: 10.1016/j.cpcardiol.2022.101438
Kyari F, Adekoya B, Abdull MM et al (2018) The current status of glaucoma and glaucoma care in Sub-Saharan Africa. Asia Pac J Ophthalmol (Phila) 7:375–386
Siegfried CJ, Shui YB, Bai F et al (2015) Central corneal thickness correlates with oxygen levels in the human anterior chamber angle. Am J Ophthalmol 159:457-462.e451
doi: 10.1016/j.ajo.2014.11.026
Tham YC, Li X, Wong TY et al (2014) Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 121:2081–2090
doi: 10.1016/j.ophtha.2014.05.013
Preussner PR, Grossmann A, Ngounou F et al (2009) Glaucoma screening in western Cameroon. Graefes Arch Clin Exp Ophthalmol 247:1671–1675
doi: 10.1007/s00417-009-1166-7
Dai J, Suo L, Xian H et al (2023) Investigating the impact of Sun/UV protection and ease of skin tanning on the risk of Pseudoexfoliation glaucoma: a Mendelian randomization study. Invest Ophthalmol Vis Sci 64:4
doi: 10.1167/iovs.64.13.4
Aburto JM, Villavicencio F, Basellini U et al (2020) Dynamics of life expectancy and life span equality. Proc Natl Acad Sci USA 117:5250–5259
doi: 10.1073/pnas.1915884117
Pelletier AL, Rojas-Roldan L, Coffin J (2016) Vision loss in older adults. Am Fam Physician 94:219–226
Murayama Y, Yamazaki S, Hasebe M et al (2022) Psychological factors that suppress help-seeking among middle-aged and older adults living alone. Int J Environ Res Public Health 19:10620
doi: 10.3390/ijerph191710620
Amoozgar B, Moghimi S, Han Y et al (2017) An update on therapeutic modalities for the prevention of angle closure glaucoma. Curr Opin Ophthalmol 28:175–180
doi: 10.1097/ICU.0000000000000350
Tehrani S (2015) Gender difference in the pathophysiology and treatment of glaucoma. Curr Eye Res 40:191–200
doi: 10.3109/02713683.2014.968935
Marques AP, Macedo AF, Perelman J et al (2015) Diffusion of anti-VEGF injections in the Portuguese national health system. BMJ Open 5:e009006
doi: 10.1136/bmjopen-2015-009006
Thurecht R, Pelly F (2020) Key factors influencing the food choices of athletes at two distinct major international competitions. Nutrients 12:924
doi: 10.3390/nu12040924